Therefore, it is of great significance to study the role of cyclic GMP-AMP synthase (cGAS)-STING signal in the progression of NAFLD and thus provide a potential target for clinical treatment. This evidence concerns the gene CGAS and metabolic dysfunction-associated steatotic liver disease.